Clinical Trials Insight: 700040591

Trial Profile

Clinical Trials Insight: 700040591

Phase of Trial: Phase II

Latest Information Update: 11 Jun 2010

At a glance

  • Drugs Tesetaxel (Primary)
  • Indications Cancer; Gastrointestinal stromal tumours; Nasopharyngeal cancer; Solid tumours; Uterine cancer
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors Genta
  • Most Recent Events

    • 11 Jun 2010 According to an ASCO abstract, twenty-six patients have been treated to date, and accrual is continuing.
    • 07 Jun 2010 Results presented at the ASCO 2010, according to a Genta media release.
    • 26 Feb 2010 Status changed from recruiting to completed, according to a Genta media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top